Recently, patients with prolactin-secreting pituitary adenoma (PRL-noma) have been widely treated by transsphenoidal hypophysectomy (Hardy 1973 ). The PRL levels of such patients are, however, not always suppressed to normal ranges even after hypophysectomy (Jaquet et al. 1978; Tindall et al. 1978 ; Barbarino et al. 1979 ; Murray et al. 1979; Casper et al. 1980 ; Schlechte and Sherman 1981) .
PRL-noma usually shows reduced or blunted responsiveness of plasma PRL to several agents (Barbarino et al. 1978; Jeske 1979; Cowden et al. 1979 ; Tucker et al. 1980) . Therefore, if the pituitary tumor was removed completely , the recovery of normal lactotrophs from the tumor compression and of PRL responsiveness to exogenous stimuli would be expected. Although there are several reports regarding the changes of responsiveness after hypophysectomy, the results are not always consistent (Barbarino et al. 1979 ; Murray et al. 1979; Tucker et al. 1980 ; Schlechte and Sherman 1981) .
In this study, we divided the PRL-noma patients into two groups according to the PRL levels obtained after hypophysectomy, namely normoprolactinemic group and hyperprolactinemic one, and evaluated the responsiveness to TRH, arginine, L-dopa, or to sulpiride before and after hypophysectomy.
MATERIALS AND METHODS
Subjects. Twenty patients with PRL-secreting adenoma (PRL-noma), 5 males and 15 females, aged 18-55 years, were involved in this study. The diagnosis of PRL-noma was made radiologically (CT-scan, tomography and plain X-ray of sella turcica), and by means of histological studies on the specimens of pituitary surgery, and/or from PRL assays (Table 1) . Sixteen cases received transsphenoidal hypophysectomy, and the remaining 4 were operated by transfrontal approach. Even after the hypophysectomy, reserves of other pituitary hormones except PRL were remained normal. None of the subject had been taking any medications throughout the study. For comparison of PRL responsiveness to the above agents, 18 normal healthy subjects, 9 males and 9 females, aged 18-22 years, were studied as a control.
Procedures. TRH (500µg ,i.v., Tanabe, Osaka), arginine (10% L-arginine HC1, 0.5 g/kg b.w., infused i.v. for 30 min, Morishita, Osaka), L-dopa (500 mg, p.o., Sankyo, Tokyo), and sulpiride (100 mg, i.m., Delagrange, Paris, France) were administered respectively before the operation and within 2 to 6 months after the hypophysectomy.
Details were reported previously al. 1982) . The procedures were started between 8 and 9 o'clock in the morning after an overnight fast. Blood samples obtained were centrifuged at 4°C and kept frozen at -27°C until assayed. Plasma PRL values were measured in duplicate with commercial RIA kits as reported elsewhere (Hanew et al. 1980a ). Sellar volume was calculated accordind to the methods of Di Chiro and Nelson (1962) . All tests of statistical significance were performed using Student's paired t test. A p value less than 0.05 was considered statistically significant.
RESULTS

Basal plasma PRL levels before and after hypophysectomy
Before hypophysectomy the basal plasma PRL in twenty cases of PRL-noma ranged from 23 to 2,408 ng/ml (mean±s.E. 364.2±122.5 ng/ml). After hypophysectomy PRL value decreased to 28.2% of the pretreatment value (102.6± 50.2 ng/ml, ranged 9.3 to 956 ng/ml) ( Table 1 ). The PRL value was normalized (below 18 ng/ml) in 9 cases (Nos. 1-9, categorized as Group I) and not normalized in the other 11 cases (Nos. 10-20, Group II) ( Table 1 , Fig. 1 ). The mean PRL values in Groups I and II were 13.2±0.8 ng/ml (range 9.3-16 ng/ml) and 175.7± 86.7 ng/ml (range 18.8-956 ng/ml), respectively.
The former value, however, In contrast, normal subjects showed significantly greater PRL responses to TRH (379.0±51.5%, n=10) than the Group II patients before or after the operation. There were, however, no significant differences between the maximal PRL responses in normal subjects and Group I patients after hypophysectomy either in percent changes (379.0±51. Plasma PRL responses to arginine in 10 patients with PRL-noma After arginine infusion plasma PRL in 10 patients showed only a subtle increase, and there were no differences between the peak values before (127.3± 11.8%) and after hypophysectomy (130.7±16.8%) (Fig. 3, left) . Again, no significant changes in the responsiveness were observed in Group I or II even after the operation (Fig. 3, center and right) . Before the hypophysectomy the with PRL-noma before and after
response in Group I was significantly greater than in Group II (p<0.05). Six normal subjects showed greater PRL responses to arginine (260.0±52.4%, n=6) than total group (p<0.02 before treatment and p<0.05 after treatment). However, the maximal PRL responses in normal subj ects were not significantly different from those in operated Group I patients either in terms of percent changes (260.0± 52.4 vs. 158.6±19.5) or in absolute values (14.9± 1.9 vs. 18.7±5.1 ng/ml). Plasma PRL responses to L-dopa in 11 patients with PRL-noma As shown in Fig. 4 , PRL responses to L-dopa in 11 patients were not changed after the surgery. The maximal PRL decreases were 37.9+7.0% of the basal value before and 41.3+4.3% after the operation (p>0.05, Fig. 4, left) . The PRL responses in Group I were higher than in Group II regardless of the treatment (p< 0.05). There were no significant differences in the maximal PRL responses between operated Group I and ten normal subjects either in percent changes (35.1± 4.0 vs. 33.7±2.9%) or in absolute values (4.0+0.9 vs. 2.9+0.3 ng/ml). Moreover, compared to normal subjects, the maximal percent decreases in total group were not statistically different, although the decreases were significantly less in Group II regardless of the treatment.
Plasma PRL responses to sulpiride in 14 patients with PRL-noma Fourteen untreated patients with PRL-noma showed a slight increase in PRL secretion to the administration of sulpiride. After the hypophysectomy they responded to the same stimulus with a marked PRL increase (Fig. 5, left) . The PRL response at 15 min was significantly (p<0.05) higher in operated group (189.7 +29.4%) than in untreated (123.6±9.0%).
Similar improvement of the responsiveness was observed either in Group I or Group 11, while the response in the former was larger than that in the latter. However, the PRL responses in these PRL-noma patients were significantly (p<0.001) lower than those in 18 normal subjects (1,684.0±168.4%). PRL-noma before and
DISCUSSION
In this study we found no alterations of PRL responsiveness to TRH, arginine, or L-dopy in terms of percent changes from the basal value in patients with PRLsecreting adenoma after the hypophysectomy. In addition, there were no significant differences in PRL responsiveness to the above three agents between the surgically normalized group and normal subjects either in percent changes or in absolute values.
In contrast, the PRL responsiveness to sulpiride improved markedly after the hypophysectomy, whereas the response in Group I patients was still lower than that in normal subjects. The normalization of PRL-responses to TRH after successful hypophysectomy confirms the previous reports (Barbarino et al. 1979; Tucker et al. 1980; Schlechte and Sherman 1981) , although these authors could not observe the distinct responses before the surgery.
A sulpiride test was employed in this study to detect the dopaminergic abnormalities in the hypothalamus and pituitary gland, since PRL is released as a result of blockade of the inhibitory dopaminergic mechanism ( The improvement of PRL responsiveness to sulpiride after the hypophysectomy in normo-and hyper-prolactinemia indicates the possibility that some alterations of dopaminergic influences on the hypothalamus and pituitary have occurred concomitantly with PRL decreases regardless of the PRL levels. However, as the PRL responsiveness to sulpiride did not normalize, the following possibilities may be considered : 1) Pituitary tumor has been removed completely, but the hypothalamic dopaminergic abnormalities persist. 2) Hypothalamic dopaminergic influences are normal, but residual tumor tissues are still secreting PRL.
3) Hypothalamic abnormalities and residual tumors coexist.
In operated Group I patients, the mean basal PRL values were significantly higher than in normal subjects. It can be assumed that the function of normal lactotropic cells around the tumor tissue is suppressed by the compression as well as by the short-and/or ultra short-loop feedback effects induced by elevated PRL levels (Hokfelt and Schlechte and Sherman 1981) . Therefore, PRL levels should be much lower than those in normal subjects if PRL-noma was removed completely. Accordingly, the high-normal PRL levels in normoprolactinemic patients after the hypophysectomy indicate the presence of residual tumors, and the PRL in systemic circulation may originate mainly from the adenoma cells. The inadequate PRL responses in PRL-noma seen after the hypophysectomy may be due to the reduced sensitivities of adenoma cells to the blocking effect of sulpiride on an inhibitory dopaminergic mechanism. We cannot, however, rule out the possibility that such inadequate responses depend more or less upon the hypothalamic dopaminergic abnormalities (Fine and Frohman 1978 
